elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q54986008-3FAA44B5-994A-41BC-98D9-B1DE709CDB2B
Q54986008-3FAA44B5-994A-41BC-98D9-B1DE709CDB2B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q54986008-3FAA44B5-994A-41BC-98D9-B1DE709CDB2B
Repurposing established cyclic adenosine monophosphate reducing agents for the prevention and therapy of epidermal growth factor receptor inhibitor resistance in non-small cell lung cancer.
P2860
Q54986008-3FAA44B5-994A-41BC-98D9-B1DE709CDB2B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q54986008-3FAA44B5-994A-41BC-98D9-B1DE709CDB2B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
8c1a80da5c52654478891f25963f6992573cea33
P2860
Expression of gamma-aminobutyric acid receptors on neoplastic growth and prediction of prognosis in non-small cell lung cancer.